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Readers are invited to use this article as a self-assessment 
exercise and to update their knowledge. 
ILLUSTRATIVE CASE HISTORY 
A 6-year-old girl in West Africa was attacked and bitten 
on the left ear by a dog in a market. As rabies was 
suspected, the dog was killed. The child suffered 
lacerations of the ear and abrasion of the adjacent scalp 
area. Her wounds were treated with an antiseptic 
solution and bandaged up. No rabies vaccine was 
available in the village. Four days later she presented at  
a Mission hospital 50 miles away. The wounds were 
cleaned with povidone iodine, and sutured. An 
intramuscular dose of a European cell culture rabies 
vaccine was given into the deltoid, and repeated 3 and 
14 days later. Rabies immune globulin (RIG) was 
not given. Twenty-three days after the bite the girl 
developed a fever, hypersalivation and restlessness. 
Dysphagia, aerophobia and coma ensued, and she died 
of presumed rabies encephalitis 2 days later. 
Comments on the case history 
Many of the difficulties of rabies prophylaxis are 
demonstrated here. Although the people in the village 
knew that rabies vaccine was needed for the child, 
information about wound cleaning was inadequate. 
Thorough washing or scrubbing with copious soap or 
detergent and water can reduce the chance of infection. 
The lipid-containing viral envelope is disrupted by soap. 
Iodine or >40% alcohol solutions may enhance the 
protection, and the wound should be left exposed to 
dry. Suturing should be avoided or delayed as virus may 
be inoculated deeper into the tissues [l]. 
The decision to use rabies prophylaxis rested on 
knowledge of the local epidemiology of rabies, the 
aggressive behavior of the animal, and the severity of 
the wounds. Testing the brain of the biting animal is 
helpful, but is rarely possible in rural areas. In any case, 
treatment should not be delayed while results are 
awaited. Vaccine can be given and the course stopped 
if appropriate laboratory tests prove negative. 
The treatment was started late. Ideally, post- 
exposure therapy is started on the day of the bite, 
and any delay increases the chance of virus entering 
a nerve ending. A potent vaccine was given intra- 
muscularly using the standard regimen, but a dose on 
day 7 was missed. There has been no evidence of loss 
of potency of the lyophilized European cell-culture 
vaccines (see below) despite lapses in the cold chain. 
RIG is recommended for all people exposed to rabies, 
and is especially important for those with lesions on the 
head, neck or hands and multiple bites [1,2], but is 
frequently not available. In Africa and Asia, only 1% of 
vaccinees received RIG in 1993 [3]. 
To summarize, there was failure to apply all three 
parts of post-exposure treatment. Immediate wound 
care was inadequate, vaccine was begun late and the 
course was incomplete, and RIG was omitted. 
Once symptoms of encephalitis have started, seda- 
tion is all that can be offered, although there may be 
a role for intensive care in some circumstances (see 
below). 
MULTIPLE-CHOICE QUESTIONS 
In each ofthe numbered questions, at least one, and up to fouq 
o f the  individual entries are correct. (The answers are at the 
end (?f this article.) 
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1. Post-exposure rabies prophylaxis 
a) Is unnecessary for a patient licked on 
the leg by a proven rabid dog True/False 
b) Is effective if given before the virus 
reaches the brain True/False 
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Should be given even if the patient 
presents 4 months after being bitten by 
a stray dog in India 
Prevents death in up to 90% of 
patients with proven exposure to rabid 
animals True/False 
Is unnecessary if the biting animal has 
been vaccinated against rabies True/False 
True/False 
Rabies vaccines 
Semple (sheep brain) and suckling 
mouse brain vaccines are no longer 
used True/False 
Rabies vaccine should ideally be 
given pre-exposure to all residents 
of countries where dog rabies is 
endemic True/False 
The standard post-exposure course 
of cell culture rabies vaccines is one 
dose intramuscularly on days 0, 3,  7 ,  
14 and 28 True/False 
Economic intradermal regimens are 
not safe for post-exposure use True/False 
Post-exposure treatment can be 
stopped if the biting dog remains 
healthy for 10 days True/False 
Rabies immune globulin 
Either equine or human RIG should 
be given in one dose at the start of 
every post-exposure vaccine course True/False 
The whole dose should be injected 
into and around the wound, if 
anatomically possible True/False 
RIG treatment is always associated 
with a risk of serum sickness True/False 
Pre-treatment intradermal skin testing 
is not necessary True/False 
R I G  neutralizes rabies virus in a 
wound and probably enhances the 
immune response to vaccine True/False 
Patients with rabies encephalitis 
May present with diarrhea and fever True/False 
Often complain of itching at the site 
of an animal bite True/False 
May attempt to bite other people True/False 
May be misdiagnosed as having 
tetanus True/False 
Have no chance of recovery True/False 
Diagnosis of rabies infection 
The diagnosis cannot be made 
during the incubation period True/False 
The diagnosis is usually made on clinical 
evidence True/False 
The diagnosis can be confirmed 
during life by isolation of virus from 
blood, tears, respiratory secretions and 
cerebrospinal fluid TrueIFalse 
A rapid method of antigen detection in 
skin biopsies has a high rate of false- 
positive results True/False 
Confirmation of the diagnosis after 
death requires a full post-mortem 
examination True/False 
Effective rabies control measures include 
Killing all stray dogs in tropical 
endemic areas True/False 
Vaccinating foxes in Europe by 
distributing live virus, in chicken 
heads or sausage baits, over the 
countryside True/False 
Distributing oral vaccine in baits 
€or dogs True/False 
Vaccinating raccoons and coyotes in 
the USA True/False 
Injecting cattle with anticoagulant to 
reduce rabies transmission by vampire 
bats True/False 
European bat lyssaviruses 
Are rabies-related viruses, distinct 
from classical street rabies virus True/False 
Are the only rabies-related viruses to 
have caused human deaths True/False 
Have occasionally been found in 
terrestrial animal species True/False 
Are also found in North America True/False 
Are susceptible to the immune 
response induced by cell-culture 
rabies vaccines True/False 
COMMENTS 
Question 1 
Post-exposure prophylaxis is not only expensive but 
carries a burden of anxiety during the months of the 
possible incubation period. Patients without any risk of 
rabies encephalitis should not be treated, and intact skin 
is a barrier against infection. An abrasion made by the 
teeth of a suspected rabid animal, or contamination of 
an existing wound by the animal’s saliva does represent 
a risk, and so does contamination of intact mucosa. The 
virus in a wound may first replicate in muscle or enter 
a motor or sensory nerve ending directly, and ascends 
in the axoplasm of peripheral nerves towards the brain 
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141. No virions are detectable at this stage, and it 
is thought that infection is transmitted by subviral 
particles, perhaps as naked nucleocapsids [5]. Once 
inside a neuron, the virus is inaccessible to immune 
attack, but infection can be prevented experimentally 
by cutting the appropriate peripheral nerve. When the 
infection reaches the brain massive intracellular viral 
replication occurs, Negri bodies form, clinical signs 
appear and there is evidence of neuronal dysfunction 
with few if any pathologic changes [4,6]. The virus 
descends back down nerves to infect many tissues, 
including the salivary glands where replication occurs 
on plasma membranes producing extracellular virus [6]. 
Post-exposure prophylaxis can probably only be 
effective before virus has entered a nerve, but as that 
time is unknown, patients should be treated irrespective 
of the time since exposure. Optimum immedmte therapy 
is virtually 100% successful, whereas the untreated 
mortality from proven rabid dog bites is estimated as 
between 35% and 57% [7,8]. A history of vaccination 
makes rabies less likely but vaccinated dogs have died 
of rabies. 
Question 2 
Rabies vaccines of nervous tissue origin are produced 
in about 13 countries. Semple vaccine is widely used 
in Asia, especially in India. Neurologic reactions, due 
to an allergic response to neural antigens, have been 
seen in 1:200 recipients [9,10]. Suckling mouse brain 
vaccine is used mainly in South America, where neuro- 
logic complications are much less frequent, but are 
more severe. Safer, more potent vaccines produced in 
cell culture are now widely distributed, and the WHO 
has recommended [ l l ]  the original human diploid 
cell vaccine (HDCV) (Pasteur Mkrieux), purified chick 
embryo cell vaccine (PCEC) (Behring) and purified 
vero cell vaccine (PVRV) (Pasteur Mkrieux). A highly 
purified duck embryo vaccine (PDEV) (Berna), which 
has not been associated with any neurologic reactions, 
is also recommended. 
Pre-exposure ininiunization is often offered to 
expatriate residents of rabies endemic areas where 
dogs comprise the dominant vector. Incorporating the 
vaccine into the routine childhood immunizations in 
these areas is a possibility in the future. Pre-exposure 
immunization is also recommended for people at risk 
through handling animals, and for laboratory workers 
and travelers. Three doses of a cell-culture vaccine are 
given on days 0, 7 and 28 (or 21), either one dose 
intramuscularly or 0.1 mL intradermally [ 1,121. 
The standard cell-culture post-exposure vaccine 
regimen requires five doses (as stated), costing >5% 
of the annual per capita income in many endemic areas. 
Two economic multiple-site intradermal post-exposure 
regimens have proved effective and are now approved 
by the WHO [3,11], The eight-site regimen uses 
vaccines in ampoules containing 1 mL (HDCV, PCEC), 
and requires eight intradermal injections of 0.1 mL 
(deltoids, suprascapular, lower-quadrant abdominal wall, 
and thighs) on day 0, four intradermal injections of 
0.1 mL (deltoids and thighs) on day 7, and a single 
intradermal dose ofO.l mL on days 28 and 91 1131. The 
two-site regimen with PVRV (0.5 mL per ampoule) 
requires 0.1-mL intradermal injections at two sites 
(deltoid areas) on days 0 , 3  and 7, and single intradermal 
0.1-mL doses on days 28 and 91 1141. 
Symptomatic rabid dogs usually die within a week. 
Isolation of virus from the saliva of apparently healthy 
dogs has been observed in Ethiopia [15], Nigeria 1161 
and India, but so rarely that the recommendations for 
post-exposure prophylaxis are unaffected. 
Question 3 
Ideally, R I G  should be given after the first dose of 
every primary post-exposure course, and is especially 
important following severe bites (see above) 11-31. RIG 
is not needed if the patient has had a complete pre- 
or post-exposure course of cell-culture vaccine, or if 
rabies-neutralizing antibody (>0.5 IU/mL) has been 
demonstrated in the past [1,3]. 
Serum sickness occurs following 1-6% of equine 
RIG treatments [17], but not after human RIG treat- 
ment. Skin testing reveals type I, IgE-mediated hyper- 
sensitivity which is rarely associated with equine RIG, 
but not the more common reactions due to comple- 
ment activation [18,19]. A positive skin test is not a 
contraindication to R I G  treatment 131, and human 
RIG can be used for patients with known allergy to 
equine products. Adrenaline must always be available to 
treat anaphylaxis immediately. 
The mechanism by which RIG enhances immunity 
is by combining with vaccine antigen to form immune 
complexes that can be taken up by antigen-presenting 
cells, which stimulate T-cell activity [20]. 
Question 4 
A wide range of non-specific prodromal signs and 
symptoms, often including fever, marks the onset of 
rabies encephalitis. Two people were infected by a 
corneal transplant from a donor who was thought to 
have died of gastrointestinal infection [21]. Neurologic 
features soon appear. Pain or parasthesiae, especially 
itching, at  the site of the bite wound occurs in about 
40% of adults, and may be intense, resulting in excoria- 
tion. Mood changes and throat symptoms can also herald 
the onset of either furious or paralytic rabies [22j. 
The more common furious form is characterized 
by hydrophobia, a combination of inspiratory muscle 
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spasm associated with terror and sometimes laryngo- 
pharyngeal spasm [23]. It is precipitated by attempts to 
drink, or a draught of air (aerophobia), or eventually 
even the sound or mention of water. General arousal, 
wild behavior and hallucinations are interrupted by 
lucid intervals when the patient may have insight into 
his condition, a distressing characteristic not seen 
in other encephalitides or tetanus. The latter can also 
be distinguished by the persistent increase in muscle 
tone. Humans do not attempt to bite other people; 
this suggests rabies phobia which has a very short 
incubation period and an excellent prognosis. Other 
consequences of neurologic disease are peripheral 
nerve lesions, and hypothalamic and autonomic system 
defects. Paralytic rabies is less common but it is charac- 
teristic of vampire bat-transmitted infections. An 
ascending flaccid paralysis with sensory signs eventually 
results in respiratory failure. 
There is no reasonable chance of recovery from 
rabies encephalitis. Thirty years ago, two patients diag- 
nosed by serology recovered; both had had nervous 
tissue vaccine post-exposure 124,251. Since then, four 
patients have survived months or years with severe 
neurologic deficits [26-281. All had had cell culture 
rabies vaccines either pre- or post-exposure. Sympto- 
matic intensive care is the only treatment available, as 
there is no evidence of benefit from steroids, RIG, 
a-interferon or antiviral agents [29]. 
Question 5 
In unvaccinated patients, rabies antibody usually appears 
in the blood during the second week of illness [30],  
and a little later in the cerebrospinal fluid (CSF). The 
diagnosis is made clinically in almost all cases outside 
the USA, but it can be confirmed during life by virus 
isolation early in infection from tears, saliva, CSF 
and brain but not from blood [31]. Kapid diagnosis 
from skin biopsies is achieved by iinniunofluorescent 
detection of antigen in nerve twiglets at  the base of hair 
follicles [32]. This is positive in 60-100% of cases 
[33,34] and there have been no reports of false-positive 
results, which have occurred with the insensitive corneal 
smear test. Antigen is similarly detected in brain smears 
(the usual method of diagnosis in animals) and can be 
used postmortem on needle biopsies of brain taken via 
the medial canthus of the eye through the superior 
orbital fissure, or via the iiuchal approach through the 
foramen niagnum. 
Question 6 
A knowledge of the local epidemioloL7 of urban and 
sylvatic (wildlife) rabies vectors is needed to implement 
control and education about prevention. Mass slaughter 
of stray dogs is an unacceptable and ineffective means 
of rabies control. Intemive dog vaccination progranis in 
urban areas have been successful (351. Oral vaccination 
with either attenuated live rabies virus or a vaccinia 
recombinant that expresses rabies glycoprotein, distri- 
buted in suitable baits, has reduced the prevalence of 
fox rabies in Europe by > 80% in 5 years [36]. N o  such 
methods are yet available for dogs, but vaccinia re- 
combinant oral vaccines are in use for raccoons, foxes 
and coyotes in the USA. Vampire bat rabies infection 
of cattle [37] causes an annual loss of millions of dollars 
in Latin America. Vampire bats are highly susceptible 
to anticoagulant at levels which are harmless to cattle. 
Warfarin treatment of cattle is therefore an effective 
method of bat population control, and hence of rabies 
transmission. 
Question 7 
The genus Lyssavivus (lyssa = rage or frenzy) of the 
rhabdovirus family comprises the rabies virus (genotype 
1) and six other genotypes [38].  Five of these have 
caused fatal human disease. Mokola (genotype 3) and 
Duvenhage (genotype 4) are restricted to Africa; 
European bat lyssaviruses (genotypes 5 and 6) have 
been found in Germany, The Netherlands, Denmark, 
Russia, Spain, France, Poland and Switzerland; and 
recently a further lyssavirus of bats (genotype 7 )  was 
discovered in Australia [39]. All except the Mokola 
virus produced clinical signs indistinguishable from 
those of classical rabies. Although only eight human 
infections have been reported, cases may have been 
missed, as virologic diagnosis is unusual and the ini- 
munofluorescent antigen detection test may be negative 
or only weakly positive with these rabies-related strains. 
There is no evidence that European bat lyssaviruses 
(EBL) infect terrestrial animal species. An EBL- 
infected bat was found in an English Channel port in 
1996 [40]. The protection afforded by cell-culture 
vaccines is probably less effective against EBL than 
against street rabies virus, but animal experiments have 
produced varying results [41]. 
All the American bat rabies strains are genotype 
1 lyssaviruses. In the USA [42], the most important 
rabies vectors, insectivorous bats, have caused 19 deaths 
since 1980 (86%) of all indigenous human cases) (C. E. 
Kupprecht, personal communication). Many patients 
gave no history of a bat bite. 
Answers to the multiple-choice questions 
41: a. True; b. False; c. True; d. False; e. False 
4 2 :  a. False; b. True; c. True; d. False; e. True 
4 3 :  a. False; b. True; c. False; d. True; e. True 
44: a. True; b. True; c. False; d. True; e. True 
4 5 :  a. True; b. True; c. False; d. False; e. False 
4 6 :  a. False; b. True; c. False; d. True; e. True 
47: a. True; b. False; c. False; d. False; e. True 
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